25 - 27 November 2026 - Corum Montpellier - France
Texte pour inciter les utilisateurs à s’inscrire.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
Texte pour inciter les utilisateurs à proposer an abstract.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
Evening of Thursday, November 26th
Texte pour inciter les utilisateurs à s’inscrire au gala. Lorem consectetur ipsum dolor sit amet, adipiscing elidam eiusmod tempor incididunt ut labore et dolore magna aliqua.
Opéra Comédie
11 Boulevard Victor Hugo,
34000 Montpellier, France
25 - 27 November 2026 - Corum Montpellier - France
Wednesday 25 November
08:30 Welcome Coffee + 09:00 Introductions
Arthritis R&D PhD Students Spotlight
Moderators: 2 Members CS Arthritis
09:30 Dione SAURAT, LP2M, Côte d’Azur University, France
Dissecting the role of calcium on collagen secretion in osteogenesis imperfecta
10:00 Jérôme GRANEL, ImmunoConcept Lab UMR 5164, Bordeaux University
Understanding haematological pre-lupus in children to prevent progression to systemic lupus
10:30 Cindy QIU, Arthritis R&D, Li2P, Sorbonne Paris North University, France
Neutrophil-mediated plasma cell differentiation and B-cell-induced osteoclast development in rheumatoid arthritis: mechanisms, impact of hypoxia and therapeutic approach
11:00 Coffee Break
11:30 Aida BOUKAMEL, UMR1173 Infection and Inflammation
Inflammatory Response and Immune System, Versailles-Saint-Quentin-en-Yvelines University
Ruminococcus gnavus: pathobiont during spondyloarthritis
12:00 Alejandro ARCO HIERVES, Paris Saclay University, France
Role of m6A methylation of RNA in salivary gland epithelial cells in Sjögren’s syndrome
12:30 Lunch Break
Highlighted of the LABELLISE programs supported by Arthritis R&D
Moderators: 2 Members CS Arthritis
14:00 Claire DAIEN, CHU Lapeyronie Montpellier, Montpellier University Hospital, France
Microbiota-gut-brain axis: prominent contributor to pain sensitization in patients with rheumatoid arthritis?
14:45 David MOULIN, Lorraine University, France
Restoring tryptophan metabolism to treat rheumatoid arthritis
15:30 Ulrich MEINZER, Pasteur Institute, Paris, France
XXXXXX
16:15 Coffee Break
Treg-based therapies
Moderators: Pascale Plence, Christian Jorgensen
17:00 Makoto MIYARA, Pitié-Salpétrière Hospital, Paris, France
Fate control of human regulatory T cells for cell therapy
17:30 Mehdi BENAMAR, Harvard, Boston, USA
A regulatory T cell Notch code to license tissue inflammation
17:50 Carole GUILLONEAU, Nantes, France
CD8+ Treg cell therapy in Transplantation and Autoimmunity: from a novel concept to a clinical reality
Thursday 26 November
08:15 Welcome Coffee
CAR-T and T-Cell engagers
Moderators: Maurine Jouret, Marc Scherlinger
09:30 KEYNOTE Fabrizio DE BENEDETTI, Bambino Gesù Children Hospital, Rome, Italy
CAR-T Cells in early-onset auto-immune diseases
09:45 Guillaume CARTRON, CHU Montpellier, France
CAR-T cell therapy in clinical practice
10:00 Bernard MAILLERE, CEA
Engineering of immune cell engagers
10:15 Eric Vivier, CIML, Marseille, France
Harnessing NK cells in cancer therapies
10:30 Coffee Break
RNA and vaccination
Moderators: Christian Jorgensen, Chantal Pichon
11:15 Chantal PICHON
The mRNA revolution: vaccines, therapeutics, and beyond
11:30 KEYNOTE Régis GERVIER, Sanofi, France
Beyond Proof-of-Concept: Toward Industrial-Scale mRNA Vaccines and Immunotherapies
12:00 KEYNOTE Norman DRZENIEK Charité, Berlin University, Germany
Cellular response mechanisms to nucleic acids and nanoparticles
12:30 Lunch Break
Metabolic signature in cancer immunotherapy
Moderators: Nathalie Bonnefoy, Dalil Hannani
14:00 KEYNOTE Mireia URIBE-HERRANZ, IDIBAPS, Barcelona, Spain
CAR-T cell immunotherapy and microbiome
14:30 Ilaria ELIA, Department of Cellular and Molecular Medicine, KU Lueven, Belgium
Metabolic regulation of anti-tumor immunity in metastatic melanoma
14:45 Mathieu LACROIX, IRCM, Montpellier, France
Tumor metabolic signature and its impact on tumor microenvironment reprogramming
15:00 Dalil HANNANI, TIMC, Grenoble University, France
Microbiota-derived metabolic signature predicts the response to immunotherapy in NSCLC patients
15:30 Coffee Break
FAI²R session
Moderators: Marie-Louise Fremond, Christophe Richez, Maxime Samson
16:00 Martin BROLY, Montpellier University Hospital, France
Development of a biological signature of the NF-KB pathway in patients with autoimmune/autoinflammatory diseases
16:30 Lisa SERIAU, University and Hospital of Rennes, France
Transcriptomic and phenotypic analysis of accessory salivary glands in dry syndrome secondary to systemic scleroderma compared to dry syndrome secondary to Sjögren’s syndrome
16:45 Benjamin FOURNIER – Imagine Institute, Necker-Enfants Malades Hospital, Paris, France
Characterisation of cellular phenotypes of EBV-infected cells in patients with T/NK-type chronic active EBV infection (CAEBV) with inflammatory or dysimmune manifestations
17:00 Raphaelle SEROR – University Hospital Kremlin-Bicêtre, Paris, France
Association between cardiovascular risk factors, cardiovascular treatments, and risk of giant cell arteritis and polymyalgia rheumatica: data from the E3N prospective cohort
17:15 Benoît BRILLAND, University and Hospital of Angers, France
Study of the role of type I interferon in the pathophysiology of ANCA-associated vasculitis
Discussion panel Patient associations
Moderators: Stéphane Taliana (AFPric), Yann Bizien (Cure51)
17:30 Patients, acteurs de la recherche clinique
Comment les patients peuvent être pro-actifs, nous aider dans la mise en place de documents, projets
Gala evening
Texte pour inciter les utilisateurs à s’inscrire au gala. Lorem ipsum dolor sit amet, consectetur adipiscing dolore magna aliqua.
Opéra Comédie
11 Boulevard Victor Hugo,
34000 Montpellier, France
Friday 27 November
08:30 Welcome Coffee
Therapeutic Innovations in Autoimmunity and Inflammatory Diseases
Moderators: Nicolas Fazilleau, Farida Djouad
09:00 KEYNOTE Melanie HAGEN, Erlangen (from Georg Schett Lab) CD19 in SLE
Novel B cell targeting in rheumtological indications
09:30 Michel COGNÉ, University and Hospital University of Rennes, France
Bespoken antibody releasing B (BAR-B) cells for therapy: meet the B-cell crew
09:45 Patrick BLANCO a été financé par la Fondation Arthritis
Tumor-derived peptide to treat inflammation
10:00 Magali IRLA, CIML Marseille, France
Rejuvenating the thymic function during aging
10:15 Coffee Break
Artificial Intelligence
Moderators: Encarnita Mariotti Ferrandiz, Kevin Yauy
10:45 Laura CANTINI, Institut Pasteur, Paris, France
Multi-modal learning for single-cell data integration
11:15 Zubeyir SALIS, Montpellier University, Montpellier, France
AI approaches to predict disease onset, trajectories, and remission in rheumatology
11:45 Anna REYMER, Grenoble University, Grenoble, France
Machine-learning approaches to uncover sequence determinants of TP53 isoform expression in normal versus cancer tissues
12:15 Samuel BITOUN, AP-HP, Hôpital Bicêtre, Kremlin-Bicêtre, France
AI to improve the diagnosis of patients with Sjögren’s disease
12:30 Lunch Break
November 25, 26, and 27, 2026
Texte pour inciter les utilisateurs à s’inscrire au Symposium. Lorem ipsum dolor…
Le Corum
Place Charles de Gaulle,
34000 Montpellier, France
Evening of Thursday, November 26th
Texte pour inciter les utilisateurs à s’inscrire au gala. Lorem ipsum dolor sit amet…
Opéra Comédie
11 Boulevard Victor Hugo,
34000 Montpellier, France
Pour rester informé.e
Formulaire et plan
Faire un don, un legs...
